SEC Form 4 · accession 0001140361-15-043584
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Enxing
Officer — VP of Sales & Marketing
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 5:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $63.23 | Dec 1, 2015 | A | 13,300 | A | — | Nov 30, 2025 | Common Stock | 13,300 | 13,300 | D |
Explanation of responses
- F11/48th of the shares subject to the option vest on each monthly anniversary measured from November 5, 2015 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.